Cargando…
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction
BACKGROUND: Interruptions in infliximab therapy are associated with the development of antibodies to infliximab (ATI), infusion reactions (IRs), and loss of response. Despite these challenges, recent observational studies suggest that reinitiating infliximab after a drug holiday can be safe and effe...
Autores principales: | Normatov, Inessa, Fluxa, Daniela, Wang, Jingzhou D, Ollech, Jacob E, Gulotta, George E, Patel, Shivani, Quintero, Maria A, De la Torre, Bety, Solis, Norma, Damas, Oriana M, Deshpande, Amar R, Kerman, David H, Abreu, Maria T, Rubin, David T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802083/ https://www.ncbi.nlm.nih.gov/pubmed/36776674 http://dx.doi.org/10.1093/crocol/otab048 |
Ejemplares similares
-
Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease
por: Khakoo, Nidah S, et al.
Publicado: (2021) -
Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing
por: Rezapour, Mona, et al.
Publicado: (2019) -
Ethnicity Influences Risk of Inflammatory Bowel Disease (IBD)-Associated Colon Cancer: A Cross-sectional Analysis of Dysplasia Prevalence and Risk Factors in Hispanics and Non-Hispanic Whites With IBD
por: Damas, Oriana M, et al.
Publicado: (2021) -
Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD
por: Damas, Oriana M., et al.
Publicado: (2022) -
Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort
por: Damas, Oriana M, et al.
Publicado: (2017)